Macrogenics (NASDAQ: MGNX) reported Q1 EPS of ($1.08), $0.11 worse than the analyst estimate of ($0.97). Revenue for the quarter came in at $2.06 million versus the consensus estimate of $5.56 million.

For earnings history and earnings-related data on Macrogenics (MGNX) click here.